A series of technological advancements for automation and parallel imaging made volume electron microscopy more user friendly while increasing throughput.
Douglas Steinberg(dsteinberg@the-scientist.com) | Nov 20, 2005 | 6 min read
Potential perils from bioterrorism to bird flu are increasingly pushing proteomics researchers to identify molecules involved in the infection process.
The normal functions of peptides that aggregate in Alzheimer’s, Parkinson’s, and Huntington’s have been largely overlooked by scientists, but some argue that they are critical for understanding the development of disease.
A controversial idea from the mid-20th century is attracting renewed attention from researchers developing theories for how cognition arises with or without a brain.
Human vs. dog brains; widespread neuronal regeneration in human adult brain; honeybee disease strikes wild insects; trouble replicating stress-induced stem cells
Glial cells were once considered neurons’ supporting actors, but new methods and model organisms are revealing their true importance in brain function.
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.